PON1 status in haemodialysis patients and the impact of hepatitis C infection.
暂无分享,去创建一个
H. Çelik | O. Erel | M. Aslan | Ş. Selek | C. Bolukbas | M. Horoz | F. F. Bolukbas | A. Koylu
[1] O. Erel,et al. Oxidative stress in hepatitis C infected end-stage renal disease subjects , 2006, BMC infectious diseases.
[2] B. Coll,et al. Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. , 2006, Journal of hepatology.
[3] I. Çelik,et al. Serum arylesterase and paraoxonase activity in patients with chronic hepatitis. , 2005, World journal of gastroenterology.
[4] B. Coll,et al. Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[5] J. Kastelein,et al. Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400052-JLR200 , 2005, Journal of Lipid Research.
[6] D. Shih,et al. The paraoxonase gene family and atherosclerosis. , 2005, Free radical biology & medicine.
[7] R. Manfro,et al. The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] E. Sarandol,et al. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. , 2004, Journal of nephrology.
[9] U. John,et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. , 2004, Atherosclerosis.
[10] J. Yodoi,et al. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection. , 2003, Kidney international.
[11] A. Yonemura,et al. R192Q paraoxonase gene variant is associated with a change in HDL-cholesterol level during dietary caloric restriction in nondiabetic healthy males. , 2003, Journal of atherosclerosis and thrombosis.
[12] A. Girolami,et al. Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. , 2002, Gastroenterologie clinique et biologique.
[13] A. Kahraman,et al. Oxidative stress markers in hepatitis C infected hemodialysis patients. , 2002, Journal of nephrology.
[14] H. Hashimoto,et al. Increased Prevalence of Carotid Atherosclerosis in Hepatitis B Virus Carriers , 2002, Circulation.
[15] J. Joven,et al. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. , 2002, Clinical chemistry.
[16] R. Nagai,et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening , 2002, The Lancet.
[17] T. Miyata,et al. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). , 2001, Kidney international. Supplement.
[18] E. Reiner,et al. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. , 2001, Croatian medical journal.
[19] J. Himmelfarb,et al. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. , 2000, Kidney international.
[20] C. Zoccali,et al. AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] V. Carreño,et al. Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease. , 2000, Cytokine.
[22] M. J. Cole,et al. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus , 2000 .
[23] D. Shih,et al. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism. , 1999, Chemico-biological interactions.
[24] B. La Du,et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. , 1999, Free radical biology & medicine.
[25] Jeetesh V. Patel,et al. Serum paraoxonase after myocardial infarction. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[26] J. Nourooz-Zadeh. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. , 1999, Methods in enzymology.
[27] T. Miyata,et al. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? , 1998, Kidney international.
[28] G. Paragh,et al. The Serum Paraoxonase Activity in Patients with Chronic Renal Failure and Hyperlipidemia , 1998, Nephron.
[29] P. Durrington,et al. Human serum paraoxonase. , 1998, General pharmacology.
[30] F. Locatelli,et al. Serologic survey for control of hepatitis C in haemodialysis patients: third-generation assays and analysis of costs. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] J. Hokanson,et al. Paraoxonase genotypes, lipoprotein lipase activity, and HDL. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[32] D. Giavarina,et al. Serum paraoxonase activity is decreased in uremic patients. , 1996, Clinica chimica acta; international journal of clinical chemistry.
[33] C. Loughrey,et al. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. , 1995, Clinical chemistry.
[34] D. Adler,et al. The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.
[35] A. Brock,et al. A New Automated Method for Phenotyping Arylesterase (EC 3.1.1.2) Based Upon Inhibition of Enzymatic Hydrolysis of 4-Nitrophenyl Acetate by Phenyl Acetate , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[36] B. La Du,et al. The human serum paraoxonase/arylesterase polymorphism. , 1983, American journal of human genetics.